Re: Security in the high-tech world of the modern pharmacy


In the previous article, Seebs <usenet-nospam@xxxxxxxxx> wrote:
Legend has it that meth labs had a much lower impact on that
legislation than the development of a new decongestent which was
still under patent, and thus profitable, unlike pseudoephedrine.

That's kind of a weird legend. For one thing, the pharmaceutical
industry lobbyists fought the new requirements pretty hard, and
they made no secret of their opposition. (For another, where is
this new compound, exactly?)
--
_+_ From the catapult of |If anyone objects to any statement I make, I am
_|70|___:)=}- J.D. Baldwin |quite prepared not only to retract it, but also
\ / baldwin@xxxxxxxxx|to deny under oath that I ever made it.-T. Lehrer
***~~~~----------------------------------------------------------------------
.